Navigation Links
Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
Date:4/18/2013

Columbia, Maryland (PRWEB) April 18, 2013

Shimadzu Scientific Instruments has introduced the DSC-60 Plus Series differential scanning calorimeters, indispensable thermal analyzers for materials characterization. The DSC-60 Plus Series offers the high-sensitivity analysis and easy operation required for the development of high-functioning new materials in the food, polymer and pharmaceutical industries.

As high-performance, general-purpose differential scanning calorimeters, the DSC-60 Plus Series offers high sensitivity and high resolution during analysis. Its new detector and unique furnace construction achieve a stable baseline across the entire measured temperature range (-140 to 600° C), as well as top-class temperature sensitivity. The eco-friendly furnace achieves more than 20 percent lower energy consumption when heating from room temperature.

A cooling chamber comes installed as standard on the DSC-60 Plus Series. The liquid-nitrogen cooling chamber permits easy measurements without the need for special accessories. Further, it achieves a cooling rate of 10° C/minute at -100° C. Its sample loading temperature function enables quick sample change without dewfall during sequential analysis.

The DSC-60A Plus model features a built-in compact autosampler, which permits automated measurement, analysis and report printout for up to 24 loaded samples. It improves the efficiency of screening during product development, as well as the efficiency of quality control activities.

Additionally, the DSC-60 Plus Series complies with various analytical laboratory regulations, including the U.S. Food and Drug Administration’s 21 CFR Part 11.

For more information about the DSC-60 Plus Series, visit http://www.ssi.shimadzu.com/products/product.cfm?product=dsc60Plus.

Abo
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
2. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
3. InnoPharma Completes $15 Million Series A Financing
4. Aratana Therapeutics Completes $15 Million Series B Financing
5. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
6. Roka Bioscience Secures $47.5 Million in Series D Financing
7. Auxogyn Completes $20 Million In Series A Funding
8. Avaxia Biologics, Inc. Closes $4.1 Million Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. NeuroPhage Extends Series B to $21.4M
10. Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORA™ Oral Calcitonin
11. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014   TRU-D SmartUVC LLC ... feature their superbug-killing UVC automated disinfection robot, TRU-D SmartUVC, at ... week from Nov. 23 to 26 at Stand 23. ... the United Kingdom,s largest infection-related event ... prevention societies to one of the leading events of its ...
(Date:11/21/2014)... CA (PRWEB) November 20, 2014 Offering ... their Sartorius Entris Balance promotion . The Sartorius ... seeking a durable, high accuracy, and easy-to-maintain balance entry ... in Germany. It was designed to help customer’s bridge ... and a balance that is very durable. Sartorius is ...
(Date:11/21/2014)... 20, 2014 The California ... research organization representing leading California academic institutions, biotechnology, ... PwC US today released a report revealing ... industry growth. The trend shows a 4 percent ... California Biomedical Industry Report indicates that, while ...
(Date:11/21/2014)... York, NY (PRWEB) November 20, 2014 ... is now available as an open access journal featuring ... with infrared fluorescent proteins to preserve photoresponsiveness in the ... Two-color fluorescent in situ hybridization using chromogenic substrates ... chips for DNA, RNA, and protein electrophoresis , ...
Breaking Biology Technology:TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3
... Nov. 12 WHO and CDC have stated that ... is "suboptimal" -- often correct less than 50% of ... are not yet accurate in,our predictions of upcoming influenza ... the United States alone., As in the case ...
... China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo,Pharmaceutical ... Shenghuo" or the,"Company"), which is engaged in ... nutritional supplement and cosmetic products,in the People,s ... NYSE Alternext,US LLC (formerly the American Stock ...
... (ASX: POH; OTCQX: PPGNY) announced today that ... trial using its patented drug,delivery system, TPM, ... non steroidal,anti-inflammatory drug (NSAID), diclofenac. The trial ... topically applied Voltaren(R) gel,(1% diclofenac), one of ...
Cached Biology Technology:A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 2A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 3NYSE Alternext US Accepts China Shenghuo's Compliance Plan for Continued Listing 4Transdermal Diclofenac enters Phase 1 Clinical Trial in Humans 2
(Date:11/7/2014)...  In conjunction with the Glendale ... Foundation of the Verdugos has announced the " GLENDALE ... $250,000 initiative to keep the Verdugo Regional Crime Lab operational ... months of existence, the Lab has processed more than 400 ... enforcement. "Because our number one priority is the ...
(Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
(Date:11/4/2014)... of death at the right time might actually help ... that could help in understanding animal populations, pest control ... paper in the journal Trends in Ecology and ... conclude that the kind of positive population effect an ... mortality, depends on the size and developmental stage of ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
... CAMBRIDGE, Mass. -- MIT biological engineers have developed a ... that have undergone a specific mutation. The work, ... marks the first time researchers have been able to ... a particular mutationin intact tissue. In this case, the ...
... of mangroves on the coasts of the Philippines could help ... that hit the islands annually. This is one of ... massive mangrove replanting, that J.H. Primavera from the Southeast Asian ... University, both in the Philippines, cite in a paper published ...
... soon as it,s begun promises to reduce the need for ... & Industry (C&I) magazine. Drilling is one ... off visiting their dentist every year. The new ... years from now, is based on Raman spectroscopy most commonly ...
Cached Biology News:MIT researchers offer glimpse of rare mutant cells 2Mangroves key to saving lives 2End in sight for the dreaded dentist drill 2
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2...
...
Biology Products: